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Abstract. Background and aim: In early 2020, SARS-CoV-2 was declared a pandemic by the WHO and 
Italy was one of the first and most severely affected country in Europe. Despite the global interest about 
COVID-19 pandemic, several aspects of this infection are still unclear, especially in pediatric population. This 
study aims to investigate the characteristics of the isolated or quarantined children and adolescents followed 
by the Public Health Department of the Italian province of Modena during the first wave of COVID-19. 
Methods: The study population included all non-adult subjects aged 0-18 years who underwent isolation or 
quarantine during the first wave of SARS-CoV-2 pandemic from February 24 to June 18, 2020 in Modena 
province, Northern Italy. Results: In Modena province, 1230 children and adolescents were isolated in case 
of SARS-CoV-2 infection (6.3%), or quarantined due to close contact with confirmed cases (88.7%) or 
travelling from a high-risk area (5.0%). Among 349 individuals who underwent swab testing, 294 (84.2%) 
reported close contact with an infected cohabiting relative and 158 (45.3%) were symptomatic. Among all 
tested subjects, 78 (22.4%) resulted positive, with a higher proportion of symptomatic subjects compared with 
the SARS-CoV-2-negative (78.2% vs. 35.8%). Fever was mostly present in SARS-CoV-2-positive children 
(48.7% vs. 12.6%). Both anosmia (58.3% vs. 41.7%) and dysgeusia (54.5% vs. 45.5%) had only slightly higher 
frequency in SARS-CoV-2-positive. Conclusions: These findings allow to expand the knowledge regarding 
characteristics of non-adult subjects isolated or quarantined during the first wave of SARS-CoV-2 pandemic. 
(www.actabiomedica.it)
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Introduction
A novel type of highly transmissible and patho-
genic coronavirus, Severe Acute Respiratory Syn-
drome Coronavirus 2 (SARS-CoV-2), emerged in 
late 2019 in China causing an acute respiratory dis-
ease, named ‘coronavirus disease 2019’ (COVID-19) 
(1,2). In early 2020, the virus spread up to be declared 
a pandemic by the WHO (3). Italy is one of the first 
and most severely affected country in Europe, with 
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its first indigenous case identified on February 21, 
2020 (4). As a consequence, in the period February-
June 2020 Italy experienced a first wave that severely 
affected mainly the North of the country (5,6), led to a 
tight lockdown (7), with regional differences possibly 
related to genetic, clinical, lifestyle, and environmental 
factors (8-15), followed by a decline in the summer 
period (4,5).
Soon after the beginning of the pandemic, diag-
nostic molecular reverse transcriptase-polymerase 
chain reaction (RT-PCR) tests based on swabs have 
been developed in order to recognize the infection sta-
tus through viral RNA detection in both symptomatic 
and asymptomatic individuals (16). Timely diagnosis 
is in fact crucial to curb virus spread (17) and control 
its impact on the population. 
COVID-19 is a potentially severe and life-threat-
ening disease with still limited therapeutic options 
(18-21), and possible long-term sequalae (22,23). Still 
in recent months that several vaccines are available 
(24), the possibility of reinfection is of concern, also 
due to the occurrence of virus variants (25,26).
Despite the tremendous impact of the disease on 
the population, especially in the elderly and vulnerable 
subjects (27), it should be noted that COVID-19 in 
children is mostly a mild disease (28-31), with a very 
low mortality rate (32-34), although growing evidence 
shows that they are as susceptible to become infected 
as adults (35). In addition, few studies were initially 
carried out in children compared with the adult popu-
lation and the elderly. Infected children usually show 
typical symptoms of acute respiratory infections, 
including fever and cough (29). However, differently 
from adults, they more likely experience extra-respira-
tory symptoms, diarrhea and vomiting being the most 
frequently reported ones (35). As a consequence, the 
incidence of COVID-19 may have been underesti-
mated in children because of an initial lack of wide-
spread testing (36).
Since the early phases of the pandemic, public 
health interventions have been established aiming 
at reducing virus spread in the population, including 
infection containment measures such as use of face 
masks and personal hygiene measures (37), closure of 
all non-essential activities (38) along with mobility 
restriction and social distancing (7). At the beginning, 
also educational settings were considered at high risk 
of infection. For this reason, lessons in presence were 
suspended in schools and universities: remote learning 
have been activated (38) along with educational inter-
ventions for the promotion of preventive measures 
among teachers and students (39). As a consequence, 
throughout the lockdown period, children and adoles-
cents remained at home with parents or relatives, and 
the transmission of SARS-CoV-2 in pediatric popula-
tion primarily occurred through infected adults mainly 
due to household contact (28,40).
Despite the global interest and concern about 
COVID-19 pandemic, several aspects of this infection 
are still puzzling (41), especially in pediatric popula-
tion characterized by much lower investigations com-
pared to adults. In this study, we aim at investigating 
the characteristics of the isolated and quarantined chil-
dren and adolescents followed by the Public Health 
Department of the Italian province of Modena during 
the first wave of COVID-19.
Methods
This study was approved by the ‘Area Vasta 
Emilia Nord’ Ethics Committee (approval no. 
AUO/0017667/20 of June 25, 2020).
Study population
Using a cross-sectional study design, we included 
all non-adult subjects aged 0-18 years who under-
went isolation or quarantine during the first wave of 
SARS-CoV-2 pandemic in Modena province, North-
ern Italy. In particular, the study population was iden-
tified through access to the database of Public Health 
Department of Modena Local Health Authority. This 
database collects information about all children and 
adolescents who underwent epidemiological inves-
tigation in the period from February 24 to June 18, 
2020. Children and adolescents were ‘isolated’ if they 
were confirmed as positive cases with reverse tran-
scriptase-polymerase chain reaction (RT-PCR) for 
SARS-CoV-2 infection (42). Conversely, they were 
‘quarantined’ if they were contact of infected individu-
als or travelling from high risk areas as assessed during 
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the epidemiological investigation (42). During both 
isolation and quarantine, children and adolescents 
were confined at their home in order to avoid virus 
transmission (43). As regards SARS-CoV-2 RT-PCR 
investigation, children and adolescents underwent 
testing when: (i) had symptoms possibly indicating 
COVID-19 (e.g., fever, cough, or other respiratory 
symptoms) and had contacts with confirmed or highly 
suspicious cases, mainly if they were the first suspi-
cious cases within their family; (ii) had contact with 
confirmed or highly suspicious cases and attended 
communities or cohabited with frail people; (iii) were 
frail subjects in contact with confirmed or highly sus-
picious cases (16,44).
Data analysis
We calculated mean, standard deviation (SD), 
and range for continuous variables, while used abso-
lute and relative (%) frequencies for categorical data. 
All analyses have been performed in the whole study 
population and in selected subgroups, in particular 
we divided the entire sample of isolated/quarantined 
children into not-tested and tested for SARS-CoV-2 
infection. Among this latter, we further divided 
according to SARS-CoV-2 positive or negative swab 
result. We also compared the study sample size with 
the overall population of Modena province (45). We 
used statistical software Stata v17.0 (StataCorp, Col-
lege Station, TX, USA, 2021) for all data analyses.
Results
Overall in the study period from February 24 to 
June 18, 2020, 1230 children and adolescents were 
isolated or quarantined in Modena province, with a 
mean age of 9.6 years (SD 4.9), ranging from 0 to 17 
years (Table 1). In particular, we included 599 females 
(48.7%) and 631 males (51.3%). Altogether, the study 
Table 1. Socio-demographic characteristics of isolated/quarantined children and adolescents from Modena province during the first 
wave from February 24 to June 18, 2020 (n=1230). Data are number (n) and percentage (%) if not differently reported.
Characteristics All subjects n (%) Tested n (%) Not tested n (%)
Overall 1230 (100) 349 (28.4) 881 (71.6)
Age† 9.6 ± 5.0 9.5 ± 5.2 9.6 ± 4.9
< 6years 311 (25.3) 99 (28.4) 212 (24.1)
6-13 years 571 (46.4) 147 (42.1) 424 (48.1)
≥14 years 348 (28.3) 103 (29.5) 245 (27.8)
Sex
Male 631 (51.3) 174 (49.9) 457 (51.9)
Female 599 (48.7) 175 (50.1) 424 (48.1)
Isolation/quarantine reason
Confirmed infection 78 (6.3) 78 (22.4) 0 (0.0)
Close contact 1091 (88.7) 268 (76.8) 823 (93.4)
Travelling from high-risk areas 61 (5.0) 3 (0.9) 58 (6.6)
Isolation/quarantine place
Home 1219 (99.1) 341 (97.7) 878 (99.7)
Hospital 5 (0.4) 5 (1.4) 0 (0.0)
Hotel 2 (0.2) 2 (0.6) 0 (0.0)
Residential community 4 (0.3) 1 (0.3) 3 (0.3)
Contagion source
Cohabiting 870 (70.7) 296 (84.8) 574 (65.2)
Non-cohabiting 360 (29.3) 53 (15.2) 307 (34.8)
Table 1 (continued)
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population corresponds to 1.06% of total non-adult 
individuals of Modena province (1230/116,225), 
with similar values in males (1.05%, 631/59,908) and 
females (1.06%, 599/56317). Subjects have been iso-
lated in case of SARS-CoV-2 infection (6.3%), or 
quarantined due to close contact with confirmed cases 
(88.7%), or travelling from a high-risk area (5.0%). In 
the overall population, 1219 (99.1%) children have 
been isolated or quarantined at home. Nine patients 
were admitted to the hospital, nobody for COVID-19.
Characteristics All subjects n (%) Tested n (%) Not tested n (%)
Contagion context
Cohabiting relative 865 (70.3) 294 (84.2) 571 (64.8)
Non-cohabiting relative 170 (13.8) 28 (8.0) 142 (16.1)
Recreational context 49 (4.0) 5 (1.4) 44 (5.0)
Health facility visits 24 (2.0) 1 (0.3) 23 (2.6)
School attendance 17 (1.4) 0 (0.0) 17 (1.9)
Flight 5 (0.4) 4 (1.2) 1 (0.1)
Other cohabiting subjects 3 (0.2) 2 (0.6) 1 (0.1)
Travelling from high-risk areas 2 (0.2) 0 (0.0) 2 (0.2)
Not reported 95 (7.7) 15 (4.3) 80 (9.1)
Symptoms
Yes 239 (19.4) 158 (45.3) 81 (9.2)
No 991 (80.6) 191 (54.7) 800 (90.8)
Admitted to hospital
Yes 9 (0.7) 9 (2.6) 0 (0.0)
No 1221 (99.3) 340 (97.4) 881 (100)
Number of siblings
0 253 (20.5) 80 (22.9) 173 (19.6)
1 533 (43.3) 155 (44.4) 378 (42.9)
2 183 (14.9) 59 (16.9) 124 (14.1)
3 44 (3.6) 18 (5.2) 26 (3.0)
≥4 28 (2.3) 20 (5.7) 8 (0.9)
Not reported 189 (15.4) 17 (4.9) 172 (19.5)
Positive cohabitants
0 162 (13.2) 25 (7.2) 137 (15.6)
1 651 (52.9) 176 (50.4) 475 (53.9)
2 143 (11.6) 54 (15.5) 89 (10.1)
3 45 (3.7) 34 (9.7) 11 (1.2)
4 23 (1.9) 21 (6.0) 2 (0.2)
≥5 15 (1.2) 15 (4.3) 0 (0.0)
Not reported 191 (15.5) 24 (6.9) 167 (19.0)
Index case removal
Yes 133 (10.8) 39 (11.2) 94 (10.7)
No 1097 (89.2) 310 (88.8) 787 (89.3)
†Mean ± standard deviation
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Exposure to SARS-CoV-2 for non-adult sub-
jects was primarily due to contact with their relatives, 
mainly cohabiting (70.7%), followed by a non-cohab-
iting relatives (13.8%). Another relevant source of 
contagion was the recreational context in 4.0% of 
subjects (e.g., contact with a friend confirmed to be 
positive for SARS-CoV-2 infection), while health 
facility visits and school attendance were reported in 
2.0% and 1.4% of subjects, respectively. Among 24 
subjects related to health facility visits, 23 had the 
same pediatrician as index case. Most children were 
asymptomatic (80.6%), while 239 (19.4%) had at least 
one symptom.
Out of 1230 children and adolescents, 349 
underwent swab testing (Table 1). Among tested par-
ticipants, 294 (84.2%) reported close contact with an 
infected cohabiting relative, and subjects with more 
than one brother or sister were tested more often. 
All the children admitted to the hospital were tested 
within hospital screening schedules. Out of the 349 
children and adolescents that underwent swab test-
ing, 158 subjects (45.3%) were symptomatic (Table 
2). Fever was recorded in 72 individuals (20.6%), fol-
lowed by cough (17.5%). Headache, rhinorrhea and 
sore throat were reported in 34 (9.7%), 33 (9.5%), 
and 25 (7.2%) subjects, respectively. Other less fre-
quent signs or symptoms included anosmia (3.4%), 
dysgeusia (3.2%), diarrhea (3.2%), vomiting (1.7%), 
conjunctivitis (2.0%), asthenia (2.0%), and respiratory 
distress (1.7%).
Among all tested subjects, 78 (22.4%) resulted to 
be positive (Table 3). A higher percentage of subjects 
with SARS-CoV-2-positive test had three or more 
infected cohabitants compared to those with negative 
swab (61.8% vs. 10.9%). A higher proportion of symp-
tomatic subjects were found in SARS-CoV-2-pos-
itive children and adolescents compared with the 
SARS-CoV-2-negative ones (78.2% vs. 35.8%).
Table 4 shows the clinical signs or symptoms 
of children and adolescents tested for SARS-CoV-2. 
Fever was the symptom mostly present in 
SARS-CoV-2-positive children (48.7% vs. 12.6%). 
Other symptoms reported by positive patients 
were cough (29.5%), headache (19.2%), sore throat 
(15.4%), and rhinorrhea (10.3%). Focusing on the 13 
and 15 children with anosmia and dysgeusia, 92.3% 
and 73.3% underwent swab testing, respectively. 
Interestingly, both anosmia (58.3% vs. 41.7%) and 
dysgeusia (54.5% vs. 45.5%) had only slightly higher 
frequency in SARS-CoV-2-positive and those who 
were negative.
Figure 1 compares the daily number of tested 
subjects along with the number of confirmed cases 
in the overall population of Modena province, and 
Table 2. Clinical signs and symptoms of children and adolescents from Modena province during the first wave from February 24 to 
June 18, 2020. Data are number (n) and percentage (%) for total population (n=1230), and divided into tested (n=349) and not tested 
(n=881) subjects.
Clinical signs and symptoms All subjects (n=1230) n (%) Tested (n=349) n (%) Not tested (n=881) n (%)
Fever 106 (8.6) 72 (20.6) 34 (3.9)
Sore throat 30 (2.4) 25 (7.2) 5 (0.6)
Cough 81 (6.6) 61 (17.5) 20 (2.3)
Diarrhea 16 (1.3) 11 (3.2) 5 (0.6)
Vomiting 7 (0.6) 6 (1.7) 1 (0.1)
Headache 40 (3.3) 34 (9.7) 6 (0.7)
Conjunctivitis 8 (0.7) 7 (2.0) 1 (0.1)
Rhinorrhea 51 (4.2) 33 (9.5) 18 (2.0)
Anosmia 13 (1.1) 12 (3.4) 1 (0.1)
Dysgeusia 15 (1.2) 11 (3.2) 4 (0.5)
Asthenia 11 (0.9) 7 (2.0) 4 (0.5)
Respiratory distress 6 (0.5) 6 (1.7) 0 (0.0)
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Table 3. Socio-demographic characteristics of children and adolescents tested for SARS-CoV-2, from Modena province during the 
first wave from February 24 to June 18, 2020 (n=349). Data are number (n) and percentage (%) if not differently reported.
Characteristics Positive swabs n (%) Negative swabs n (%)
Overall 78 (22.3) 271 (77.7)
Age† 10.0 ± 5.4 9.4 ± 5.2
<6 years 18 (23.1) 81 (29.9)
6-13 years 35 (44.9) 112 (41.3)
 ≥14 years 25 (32.0) 78 (28.8)
Sex
Male 33 (42.3) 141 (52.0)
Female 45 (57.7) 130 (48)
Isolation/quarantine place
Home 72 (92.3) 269 (99.2)
Hospital 4 (5.1) 1 (0.4)
Hotel 2 (2.6) 0 (0.0)
Residential community 0 (0.0) 1 (0.4)
Contagion source
Cohabiting 61 (78.2) 235 (86.7)
Non-cohabiting 17 (21.8) 36 (13.3)
Contagion context
Cohabiting relative 61 (78.2) 233 (86.0)
Non-cohabiting relative 6 (7.7) 22 (8.1)
Recreational context 2 (2.6) 3 (1.1)
Health facility visits 0 (0.0) 1 (0.4)
School attendance 0 (0.0) 0 (0.0)
Flight 0 (0.0) 4 (1.5)
Other cohabiting subjects 0 (0.0) 2 (0.7)
Travelling from high-risk areas 0 (0.0) 0 (0.0)
Not reported 9 (11.5) 6 (2.2)
Symptoms
Yes 61 (78.2) 97 (35.8)
No 17 (21.8) 174 (64.2)
Admitted to hospital
Yes 6 (7.7) 3 (1.1)
No 72 (92.3) 268 (98.9)
Number of siblings
0 24 (30.8) 56 (20.7)
1 34 (43.6) 121 (44.6)
2 14 (17.9) 45 (16.6)
3 5 (6.4) 13 (4.8)
≥4 0 (0.0) 20 (7.4)
Not reported 1 (1.3) 16 (5.9)
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Characteristics Positive swabs n (%) Negative swabs n (%)
Positive cohabitants
0 3 (3.8) 22 (8.1)
1 11 (14.1) 165 (60.9)
2 12 (15.4) 42 (15.5)
3 18 (23.1) 16 (5.9)
4 13 (16.7) 8 (3.0)
≥5 11 (14.1) 4 (1.5)
Not reported 10 (12.8) 14 (5.2)
Index case removal
Yes 4 (5.1) 35 (12.9)
No 74 (94.9) 236 (87.1)
†Mean ± standard deviation
Table 4. Clinical signs or symptoms of children and adolescents tested for SARS-CoV-2 from Modena province during the first 
wave from February 24 to June 18, 2020. Data are number (n) and percentage (%) according to subjects with positive (n=78), negative 
swabs (n=271).
Clinical signs or symptoms Positive swabs (n=78) n (%) Negative swabs (n=271) n (%)
Fever 38 (48.7) 34 (12.6)
Sore throat 12 (15.4) 13 (4.8)
Cough 23 (29.5) 38 (14.0)
Diarrhea 6 (7.7) 5 (1.9)
Vomiting 2 (2.6) 4 (1.5)
Headache 15 (19.2) 19 (7.0)
Conjunctivitis 2 (2.6) 5 (1.9)
Rhinorrhea 8 (10.3) 25 (9.2)
Anosmia 7 (9.0) 5 (1.9)
Dysgeusia 6 (7.7) 5 (1.9)
Asthenia 4 (5.1) 3 (1.1)
Respiratory distress 3 (3.8) 3 (1.1)
shows that in the early phase of first wave non-adult 
subjects were tested for SARS-CoV-2 less frequently 
than adults.
Similarly, we compared the daily number of RT-
PCR tested subjects with the number of  confirmed 
SARS-CoV-2 cases and subjects with symptoms 
in the pediatric population of Modena province 
(Figure 2). The number of pediatric swab testing 
 rapidly increased from the beginning of May, 2020, 
without an increase of the confirmed cases or symp-
tomatic subjects.
Discussion
This study aims to investigate the characteristics 
among children and adolescent during the first wave 
of the COVID-19 pandemic in a province of North-
ern Italy. According to previous findings, the results 
of our research confirm that during the first wave, 
characterized by a tight lockdown, the transmission of 
SARS-CoV-2 occurred through household exposure 
(28,40), especially in non-adult population as 85.9% of 
infected children had a positive relative. Interestingly, 
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approximately three out of five children with posi-
tive swab test had three or more infected cohabitants. 
This highlights the importance of proper isolation and 
physical distancing, also during home quarantine, in 
order to avoid the risk of infection (46).
Based on epidemiological investigation, school 
contact was recorded in 17 (1.4%) individuals only. 
However, it is important to underline that in Italy 
schools were closed at the beginning of March 2020, 
and have been locked for the remaining study period 
(47). As a consequence, during the first wave the pro-
longed closure of schools does not seem to have played 
a relevant role on the spread of the pandemic accord-
ing to available data (48), while it has been associated 
with greater stress and discomfort for children and 
adolescents (49). Our findings are similar with other 
studies that suggested a low transmission in schools 
measuring incidence in school-aged children and ado-
lescents before and during school closures (50,51). 
Interestingly, a study carried out in Reggio Emilia (a 
province close to Modena within the same Emilia-
Romagna region) reported similar results in terms of 
transmission in preschools and elementary schools, 
but not in secondary schools (52). Overall, our results 
suggest a limited role of children in virus spread dur-
ing the first wave, in line with other studies (32,53). 
Conversely during the second wave, an increased risk 
Figure 1. The daily number of tested non adult subjects and the 
number of confirmed cases in the overall population of Modena 
province during the first wave from February 24 to June 18, 
2020. Solid and dashed lines indicate the begin (March 9, 2021) 
and end (May 3, 2021) of tight lockdown period, respectively.
Figure 2. The daily number of tested subjects, the number of 
confirmed cases and subjects with symptoms in the pediatric 
population of Modena province during the first wave from Feb-
ruary 24 to June 18, 2020. Solid and dashed lines indicate the 
begin (March 9, 2021) and end (May 3, 2021) of tight lock-
down period, respectively.
of reported SARS-CoV-2 infection and COVID-19 
outcomes was reported among adults living with chil-
dren, although this was not followed by an increased 
mortality (54).
Comparing characteristics from tested group with 
not tested groups, testing strategies have privileged the 
presence of predictive or risk factors such as: being 
symptomatic (especially fever, cough and headache), 
having more than one brother or sister, having more 
than two positive cohabitants, and hospitalization. 
About this latter, however, it should be noted that the 
data about swab testing in hospitalized children are 
related to routine screening plans set-up for all sub-
jects before admission to emergency room or hospital.
In our study population, the prevalence of con-
firmed pediatric cases that were asymptomatic is 21.8%, 
similar to a previous study (55). The clinical presen-
tation in non-adult population with SARS-CoV-2 
includes different possible scenarios characterized by 
a high variation of severity (56). Our findings indi-
cate that subjects with a positive swab reported mostly 
fever (48.7%), cough (29.5%), headache (19.2%), sore 
throat (15.4%) and rhinorrhea (15.4%), overall dem-
onstrating a major involvement of respiratory sys-
tem among children and adolescents. Nevertheless, 
during the study period, the recommendations on 
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SARS-CoV-2 case identification indicated RT-PCR 
testing only for selected non-adult subjects, such as 
symptomatic or frail individuals in contact with con-
firmed or highly suspicious cases. As a matter of that, 
main reasons for RT-PCR testing were if the subject 
was the first suspicious case within the family or was 
the contact of confirmed or highly suspicious cases 
while attended communities or cohabited with frail 
people people. As a consequence, the prevalence of 
other presentations (e.g., gastrointestinal, neurological 
and cutaneous) may have been underestimated in this 
study, as well as in other studies (17). Interestingly, in 
contrast with what observed in literature (17), specific 
clinical features such as anosmia and dysgeusia show 
only marginal difference between the SARS-CoV-2 
positive and negative individuals, suggesting that these 
symptoms might have a minor pathognomonic role in 
pediatric population.
The low number of tested children can be 
explained by the observation that pediatric individuals 
are more likely asymptomatic or show milder symp-
toms, therefore, they may have been less often tested 
or received a positive results as shown in other studies 
(29,30,32,35), thus affecting the prevalence of positive 
cases compared to the overall population (36). At the 
beginning of pandemic, most countries including Italy 
have chosen to test only symptomatic patients due to 
the limited availability of swab tests (16). Also inter-
national recommendations (16) underline that testing 
strategies must be adapted in order to ensure an opti-
mal use of resources and alleviate pressure on labora-
tories. In order to save resources, in early stages of the 
COVID-19 pandemic, the indication was to de-prior-
itize testing of mildly symptomatic patients or patients 
who were not in risk groups (16). Furthermore, after 
the first positive case in a closed setting (e.g., cluster 
among workers or relatives), all other individuals with 
symptoms related to the same cluster may be consid-
ered probable cases and quarantined without addi-
tional testing, especially when testing capacity was 
limited (44). According to these recommendations 
and to our results, during the first pandemic wave, a 
small number of children has been tested because they 
were mostly asymptomatic and therefore they were 
just quarantined at home without additional investi-
gation. This inherently limits the external validity of 
our findings and related considerations, since only a 
systematic population-based testing could allow a 
complete epidemiologic picture of the viral spread in 
a community, including children (57).
The number of pediatric swab testing rapidly 
increased when the lockdown started to ease at the 
beginning of May 2020. The possible reasons might 
be that, after the lockdown and the decrease of posi-
tive cases, more resources were available to test mild 
and asymptomatic individuals, leading to an increase 
in tested children and adolescents. In addition, the 
increased sources of exposure to the infection as a 
consequence of resume social interactions, including 
school attendance for children, explain why the num-
ber of tests strongly increased after the first wave (5).
In Italy and in general in other countries, increased 
testing has contributed to a better detection of ongoing 
transmission (36). In early phases of the COVID-19 
pandemic, pediatric cases may have been undetected 
or underestimated. However, our data (Figure 2) show 
that in the first weeks after the reopening, compared 
with the lockdown period, the pediatric case distri-
bution was similar. This can suggest that, in order to 
save limited testing resources, prioritize symptomatic 
patients has been a proper strategy.
This study is limited by the number of swab tests 
(RT-PCR) for SARS-CoV-2 infection due to the 
shortage of resources. Indeed, serological assays that 
detect antibodies anti-SARS-CoV-2 were used as 
support of swab tests in various settings, especially 
in workplaces (58), despite they had limited diagnos-
tic application in early stages of the pandemic, being 
especially helpful to better understand the extent of the 
infection in the community (59). Another limit of our 
investigations is that we could not investigate deeply 
transmissions in education settings and those related 
to activities and behaviors outside of school, such as 
using public transportation or recreational activities 
due to the closures. Nevertheless, also considering the 
limited evidence available on this topic, our findings 
expand the knowledge regarding characteristics of 
non-adult subjects quarantined during the first wave 
of SARS-CoV-2 pandemic. Some strengths should 
also be outlined. The epidemiological investigations 
carried out by the Local Health Authorities were man-
datory for all Italian population thank to the efforts 
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of Public Health Departments since the beginning of 
the pandemic (60), thus occurrence of selection bias 
can be ruled out. In addition, the detailed epidemio-
logical investigation of the included subjects allowed 
us to investigated several determinants associated with 
isolation and testing in the pediatric population (61). 
Similarly, the thorough assessment of clinical signs 
and symptoms provide additional and helpful insights 
about the clinical presentation of COVID-19 in the 
pediatric population characterized by different features 
compared to adults (33).
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